T. Polascik

发表

Synthesis and evaluation of 18F-labeled choline as an oncologic tracer for positron emission tomography: initial findings in prostate cancer.

R. Coleman, T. Polascik, T. DeGrado, 2001, Cancer research.

Focal therapy in prostate cancer-report from a consensus panel.

M Emberton, R Montironi, T. D. de Reijke, 2010, Journal of endourology.

Salvage prostate cryoablation after primary interstitial brachytherapy failure: a feasible approach

T. Polascik, V. Mouraviev, B. Evans, 2006, Prostate Cancer and Prostatic Diseases.

Predicting non-organ-confined prostate cancer in men diagnosed after 2000

J. Moul, T. Polascik, C. Robertson, 2010, Prostate Cancer and Prostatic Diseases.

Sexual bother and function after radical prostatectomy: predictors of sexual bother recovery in men despite persistent post‐operative sexual dysfunction

J. Moul, L. Gerber, L. Bañez, 2013, Andrology.

Concordance in the perception of couples recovering from primary surgical treatment of prostate cancer

V. Mouraviev, T. Polascik, T. Polascik, 2009, International Journal of Impotence Research.

Issues Critical to the Successful Application of Cryosurgical Ablation of the Prostate

J. Cohen, T. Polascik, A. Gage, 2007, Technology in cancer research & treatment.

Use of multivariate models to improve prediction of pathologic stage for men with clinically localized prostate cancer

A. Partin, T. Polascik, J. Pearson, 1998, Prostate Cancer and Prostatic Diseases.

Patient selection for prostate focal therapy in the era of active surveillance: an International Delphi Consensus Project

J. Coleman, H. Ahmed, L. Klotz, 2017, Prostate Cancer and Prostatic Diseases.

Does mpMRI improve clinical criteria in selecting men with prostate cancer for active surveillance?

J. Moul, T. Polascik, T. Polascik, 2017, Prostate Cancer and Prostatic Diseases.

Race is associated with discontinuation of active surveillance of low-risk prostate cancer: Results from the Duke Prostate Center

Michael N. Ferrandino, J. Moul, S. Freedland, 2012, Prostate Cancer and Prostatic Diseases.

WITHDRAWN: Can the conventional sextant prostate biopsy reliably diagnose unilateral prostate cancer in low-risk, localized, prostate cancer?

J. Madden, T. Polascik, J. Mayes, 2008, Prostate cancer and prostatic diseases.

Disparate results between proliferation rates of surgically excised prostate tumors and an in vitro bioassay using sera from a positive randomized controlled trial

J. Moul, J. Moul, W. Demark-Wahnefried, 2015, Biotechnic & histochemistry : official publication of the Biological Stain Commission.

African-American men with low-grade prostate cancer have higher tumor burdens: Results from the Duke Prostate Center

J. Moul, L. Gerber, L. Bañez, 2012, Prostate Cancer and Prostatic Diseases.